$0.091
-0.061 (-67.02%)收盤時
- 最高
- 0.157
- 開盤
- 0.137
- 成交量加權均價
- 0.11
- 成交量
- 70.12M
- 市值
- —
- 最低
- 0.091
- 成交金額
- 7.90M
- 企業價值/稅息折舊攤銷前利潤(TTM)
- -8.03
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
AI 分析 of Synergy CHC Corp (SNYR)
賣出Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.
估值指標
事件時間軸
資訊
9.505-15seekingalphaSynergy CHC Reports Q1 Loss with Revenue Decline
9.504-02seekingalphaSynergy CHC Reports FY 2025 Earnings Results
9.504-01Yahoo FinanceSynergy CHC Corp Reports Significant Q4 Losses Amid Revenue Decline
9.503-30NewsfilterSynergy CHC Corp. Updates Q4 and Full Year 2025 Financial Results Release Date
1.002-21Yahoo FinanceNew Show to Air Tonight on Bloomberg Television
SNYR 常見問題 —— 由 Alphio AI 解答
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications. It operates in the Healthcare sector.
Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。